FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for Diclofenac Sodium/Misoprostol (Diclofenac-Sodium-Misoprostol) from Micro Labs Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Gastric Ulcer
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Diclofenac sodium misoprostol (diclofenac sodium and misoprostol)

Snippet

SUPPL AP for DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL (DICLOFENAC SODIUM/MISOPROSTOL)